Aurora Cannabis Inc.

TSX:ACB.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$6.31 +0.48%

+$0.02 today

Market cap
$414.85M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $3.77High $9.33

Volume 0.32M

Average 0.42M

ACB.TO Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Aurora Cannabis Inc.TSX: ACB.TO

Depreciation & Amortization · Q4 FY2026 · quarter ended Mar 2026

Depreciation & amortization turns negative

Q4 FY2026 depreciation & amortization was -CA$4.62M, compared with CA$5.95M a year earlier. Trailing-twelve-month depreciation & amortization was CA$13.39M. Over 3 fiscal years it compounded at -31.2% a year.

Context

  • Depreciation & amortization amounted to 4.4% of revenue in FY2026, down 2.1 pp from a year earlier.
  • Depreciation & amortization increased in 0 of the last 3 fiscal years.
  • FY2026 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly depreciation & amortization holds near -CA$4.62M or moves back toward the trailing-twelve-month quarterly average of CA$3.35M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$4.62M-172.2% QoQ
Last fiscal yearMar 2026
CA$14.19M-37.1% YoY
LTMMar 2026
CA$13.39M-40.6% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-177.6%——
1 year-37.1%——
3-year CAGR-31.2%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

CAD · from the income statement

Latest · FY2026
14.19M CAD
Year-over-year change
-37.1%
4-year CAGR
-37.6%

Depreciation & Amortization vs competitors

How ACB.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -40.6% is the lowest of 8, against a peer median of +14.9%.
  • Depreciation & amortization amounts to 4.2% of revenue for ACB.TO, versus a peer median of 7.5%.
ACB.TO Competitors
Depreciation & Amortization for ACB.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$40.12M CAD-6.9%-23.0%12.9%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$19.76M CAD+37.8%—7.2%
TSND.TOTerrAscend Corp.LTM Mar 2026$16.18M USD-28.9%-10.7%6.2%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$13.39M CAD-40.6%-31.2%4.2%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$11.86M CAD+14.9%-17.2%7.5%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$7.19M USD+29.5%+94.1%14.1%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$253K CAD+2.0%-2.8%9.2%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$128K USD+24.3%-11.6%0.3%
Peer median (excluding ACB.TO) —+14.9%-11.2%7.5%

Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M233.29M270.28M343.29M320.59M
Cost of Revenue200.11M297.65M138.82M155.69M303.89M
Gross Profit21.23M(64.36M)131.46M187.61M16.7M
Gross Margin9.6%-27.6%48.6%54.6%5.2%
Research & Development10.39M6.56M3.57M3.68M4.02M
Selling, General & Admin188.99M183.4M156.88M166.47M173.5M
Operating Expenses252.67M189.96M177.91M182.66M179.5M
Depreciation & Amortization93.66M43.57M33.07M22.55M14.19M
EBITDA(1.55B)(210.74M)(12.34M)51.35M(162.79M)
EBITDA Margin-702.4%-90.3%-4.6%15.0%-50.8%
Operating Income(231.45M)(254.32M)(46.45M)4.95M(162.79M)
Operating Margin-104.6%-109.0%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.85M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(41.1M)(13.15M)15.43M106.27M
Income Before Tax(1.72B)(295.42M)(59.6M)20.38M(56.52M)
Pre-Tax Margin-777.1%-126.6%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)(20.32M)(554K)4.62M2.1M
Net Income(1.72B)(265.33M)(69.33M)1.59M(121.76M)
Net Margin-776.0%-113.7%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

TSX:ACB.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.